Fatty Acid Synthase Modulates Homeostatic Responses to Myocardial Stress*
暂无分享,去创建一个
G. Dorn | J. Saffitz | C. Nichols | C. Semenkovich | P. Schulze | D. Kelly | B. Razani | V. Topkara | J. Schilling | I. Lodhi | C. Feng | T. Coleman | A. Kovács | J. Verbsky | Haixia Zhang | Chu Feng
[1] J. Schneider,et al. Macrophage Fatty-acid Synthase Deficiency Decreases Diet-induced Atherosclerosis* , 2010, The Journal of Biological Chemistry.
[2] J. Nerbonne,et al. Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents. , 2010, Journal of molecular and cellular cardiology.
[3] F. Gao,et al. The Cytoprotective Effects of Tumor Necrosis Factor Are Conveyed Through Tumor Necrosis Factor Receptor–Associated Factor 2 in the Heart , 2010, Circulation. Heart failure.
[4] E. Abel,et al. Rodent models of diabetic cardiomyopathy , 2009, Disease Models & Mechanisms.
[5] John Turk,et al. Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver , 2009, Cell.
[6] U. Schotten,et al. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. , 2009, The Journal of clinical investigation.
[7] M. Anderson. CaMKII and a failing strategy for growth in heart. , 2009, The Journal of clinical investigation.
[8] Tong Zhang,et al. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. , 2009, The Journal of clinical investigation.
[9] M. Kendrick,et al. Lysophosphatidyl choline modulates mechanosensitive L-type Ca2+ current in circular smooth muscle cells from human jejunum. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[10] Hugo A. Katus,et al. The δ isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload , 2009, Proceedings of the National Academy of Sciences.
[11] C. Nichols,et al. Secondary consequences of beta cell inexcitability: identification and prevention in a murine model of K(ATP)-induced neonatal diabetes mellitus. , 2009, Cell metabolism.
[12] H. Shimano. SREBPs: physiology and pathophysiology of the SREBP family , 2009, The FEBS journal.
[13] F. Saleem,et al. Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels , 2008, Proceedings of the National Academy of Sciences.
[14] M. Loda,et al. Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer , 2008, Laboratory Investigation.
[15] Linda M. Boland,et al. Polyunsaturated Fatty Acid Modulation of Voltage-Gated Ion Channels , 2008, Cell Biochemistry and Biophysics.
[16] L. Glimcher,et al. Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.
[17] L. Satin,et al. Differential modulation of L-type calcium channel subunits by oleate. , 2008, American journal of physiology. Endocrinology and metabolism.
[18] Yukio Horikawa,et al. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. , 2008, Endocrine journal.
[19] T. Baukrowitz,et al. How Highly Charged Anionic Lipids Bind and Regulate Ion Channels , 2008, The Journal of general physiology.
[20] Y. Ikeda,et al. Toward biologically targeted therapy of calcium cycling defects in heart failure. , 2008, Physiology.
[21] M. Link,et al. Parasympathetic response in chick myocytes and mouse heart is controlled by SREBP. , 2008, The Journal of clinical investigation.
[22] M. Lane,et al. Brain fatty acid synthase activates PPARα to maintain energy homeostasis , 2007 .
[23] Donald M Bers,et al. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. , 2007, Cardiovascular research.
[24] Lan Cheng,et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. , 2006, Developmental cell.
[25] A. Terzic,et al. Protection conferred by myocardial ATP‐sensitive K+ channels in pressure overload‐induced congestive heart failure revealed in KCNJ11 Kir6.2‐null mutant , 2006, The Journal of physiology.
[26] Jeffrey W. Smith,et al. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Mark E. Anderson,et al. RETRACTED: L-Type Ca2+ Channel Facilitation Mediated by Phosphorylation of the β Subunit by CaMKII , 2006 .
[28] S. Endo,et al. Mechanisms for association of Ca2+/calmodulin-dependent protein kinase II with lipid rafts. , 2006, Biochemical and biophysical research communications.
[29] M. Daly,et al. Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB Activation , 2006, Molecular and Cellular Biology.
[30] Sheryl E. Koch,et al. The L-type calcium channel in the heart: the beat goes on. , 2005, The Journal of clinical investigation.
[31] T. Flagg,et al. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). , 2005, Journal of molecular and cellular cardiology.
[32] R. Liao. Yin and Yang of Myocardial Transforming Growth Factor-&bgr;1: Timing Is Everything , 2005, Circulation.
[33] J. Schneider,et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.
[34] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[35] Guy Salama,et al. Calmodulin kinase II inhibition protects against structural heart disease , 2005, Nature Medicine.
[36] Masaki Inagaki,et al. Calcium/Calmodulin-dependent Protein Kinase II (CaMKII) Localization Acts in Concert with Substrate Targeting to Create Spatial Restriction for Phosphorylation* , 2005, Journal of Biological Chemistry.
[37] M. Weis,et al. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium. , 2004, Cardiovascular research.
[38] J. Nerbonne,et al. Heterogeneous expression of repolarizing, voltage‐gated K+ currents in adult mouse ventricles , 2004, The Journal of physiology.
[39] M. Anderson. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.
[40] F. Charpentier,et al. Remodeling of excitation-contraction coupling in transgenic mice expressing ATP-insensitive sarcolemmal KATP channels. , 2004, American journal of physiology. Heart and circulatory physiology.
[41] R. Hammer,et al. Hypertrophic Response to Angiotensin Ii Cardiac Function and an Unaltered Receptor Knockout Mice Have Normal Cardiomyocyte-specific Endothelin A , 2003 .
[42] L. Miller,et al. Alterations of gene expression in failing myocardium following left ventricular assist device support. , 2003, Physiological genomics.
[43] Andrzej Witkowski,et al. Structural and functional organization of the animal fatty acid synthase. , 2003, Progress in lipid research.
[44] S. Chirala,et al. Fatty acid synthesis is essential in embryonic development: Fatty acid synthase null mutants and most of the heterozygotes die in utero , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[45] Tong Zhang,et al. The &dgr;C Isoform of CaMKII Is Activated in Cardiac Hypertrophy and Induces Dilated Cardiomyopathy and Heart Failure , 2003, Circulation research.
[46] A. Terzic,et al. Kir6.2 is required for adaptation to stress , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[47] Dan M Roden,et al. Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy , 2002, Circulation.
[48] S. Woodman,et al. Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.
[49] D. Severson,et al. A Role for Peroxisome Proliferator-activated Receptor α (PPARα) in the Control of Cardiac Malonyl-CoA Levels , 2002, The Journal of Biological Chemistry.
[50] D. Bers. Cardiac excitation–contraction coupling , 2002, Nature.
[51] G. Christ,et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.
[52] W Grossman,et al. LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice. , 2001, American journal of physiology. Heart and circulatory physiology.
[53] M. Weckström,et al. Cardiac mechanotransduction: from sensing to disease and treatment. , 2001, Trends in pharmacological sciences.
[54] P. Herrero,et al. A novel mouse model of lipotoxic cardiomyopathy. , 2001, The Journal of clinical investigation.
[55] M. Bitzer,et al. Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.
[56] P. Jones,et al. Tenascin-C in development and disease: gene regulation and cell function. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[57] J. Ju,et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice , 2000, Nature Medicine.
[58] K. Ueno. Involvement of fatty acid synthase in axonal development in mouse embryos , 2000, Genes to cells : devoted to molecular & cellular mechanisms.
[59] R. Passier,et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. , 2000, The Journal of clinical investigation.
[60] K. Kim,et al. Regulation of the fatty acid synthase promoter by insulin. , 2000, The Journal of nutrition.
[61] G. J. van der Vusse,et al. Cardiac fatty acid uptake and transport in health and disease. , 2000, Cardiovascular research.
[62] P. Dunham,et al. Molecular cloning and functional characterization of KCC3, a new K-Cl cotransporter. , 1999, American journal of physiology. Cell physiology.
[63] D. Severson,et al. Glucose and fatty acid metabolism in the isolated working mouse heart. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[64] W. Wahli,et al. Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting , 1999 .
[65] Mark E. Anderson,et al. CaM kinase augments cardiac L-type Ca2+ current: a cellular mechanism for long Q-T arrhythmias. , 1999, American journal of physiology. Heart and circulatory physiology.
[66] M. Hellerstein. De novo lipogenesis in humans: metabolic and regulatory aspects , 1999, European Journal of Clinical Nutrition.
[67] G. Dorn,et al. Decompensation of Pressure-Overload Hypertrophy in Gαq-Overexpressing Mice , 1998 .
[68] P. Karczewski,et al. Differentiation‐dependent expression of cardiac δ‐CaMKII isoforms , 1998 .
[69] B. A. French,et al. Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.
[70] C. Semenkovich,et al. Regulation of fatty acid synthase (FAS). , 1997, Progress in lipid research.
[71] H. C. Hartzell,et al. Effect of arachidonic acid on the L‐type calcium current in frog cardiac myocytes. , 1996, The Journal of physiology.
[72] R. Walsh,et al. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. , 1995, Circulation research.
[73] D. Dietzen,et al. Caveolin Is Palmitoylated on Multiple Cysteine Residues , 1995, The Journal of Biological Chemistry.
[74] G. Dorn,et al. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. , 1994, The American journal of physiology.
[75] R. Reneman,et al. Fatty acid homeostasis in the normoxic and ischemic heart. , 1992, Physiological reviews.
[76] T. Shimada,et al. Modulation of voltage-dependent Ca channel current by arachidonic acid and other long-chain fatty acids in rabbit intestinal smooth muscle , 1992, The Journal of general physiology.
[77] J. Ross,et al. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[78] N. Dhalla,et al. Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. , 1983, The American journal of physiology.
[79] J. Oram,et al. Regulation of fatty acid utilization in isolated perfused rat hearts. , 1973, The Journal of biological chemistry.
[80] J. R. Evans. Importance of Fatty Acid in Myocardial Metabolism , 1964, Circulation research.
[81] R. Bing,et al. Myocardial metabolism of fatty acids. , 1960, The Journal of clinical investigation.
[82] L. Adorini,et al. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. , 2007, Methods in molecular biology.
[83] J. Sadoshima,et al. The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.